Asthma pills as effective as inhalers

By Admin
Researchers are saying that a one-a-day pill is just as, if not more than effective at treating asthma than traditional inhalers. It is thought the new...

Researchers are saying that a one-a-day pill is just as, if not more than effective at treating asthma than traditional inhalers.

It is thought the new tablet could revolutionise asthma treatments, because people may prefer to take a tablet as many find inhalers difficult to use.

According to the report in the New England Journal of Medicine asthma sufferers had as much symptom relief after taking the tablets as they get from using an inhaler.

READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Exec Digital, click here
Sex and coffee can trigger strokes

Headaches cost world economy £140 billion a year

Superfruit cocktail has super heart benefits

Although the leukotriene receptor antagonists (LTRAs) tablets – known by their brand names of Singulair and Accolate – have been available for years, they are much less prescribed than inhalers.

A team of researchers from the University of East Anglia (UEA) in the UK tested 650 local patients aged 12 to 80 and found that 80 percent would be able to take the asthma pill instead of using an inhaler.

In the UK approximately 5.4 million people have asthma, and 1.1 million of those are children.

Dr Stanley Musgrave, co author of the report, said: “The tablet may provide an alternative that can be as effective as an inhaler.”

“What the study basically says to a doctor or nurse when working with a patient is that this is something they may want to consider as well as the standard therapies.”

He added: “The medication is available on the NHS, it's just been a lower or a second choice.”

Although previous studies have shown that inhalers outperformed the asthma tablets in randomized settings, experts say this most recent study is much more similar to a real-world setting. 

Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI